CDH2 and head and neck squamous cell carcinoma: A recent study demonstrates that the so-called “cadherin-switch”, characterized by the loss of E-cadherin and the emergence of de novo expression of N-cadherin in the invasion front of recurrent HNSCC, is a consistent histological feature.